Accessibility Menu
 
Ono Pharmaceutical logo

Ono Pharmaceutical

(OTC) OPHLY

Current Price$4.86
Market Cap$6.85B
Since IPO (2012)+24%
5 Year-44%
1 Year+30%
1 Month-10%

Ono Pharmaceutical Financials at a Glance

Market Cap

$6.85B

Revenue (TTM)

$514.13B

Net Income (TTM)

$63.40B

EPS (TTM)

$0.30

P/E Ratio

16.36

Dividend

$0.18

Beta (Volatility)

0.24 (Low)

Price

$4.86

Volume

33,038

Open

$4.87

Previous Close

$4.86

Daily Range

$4.83 - $4.87

52-Week Range

$3.28 - $5.75

OPHLY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Ono Pharmaceutical

Industry

Pharmaceuticals

Employees

4,287

CEO

Gyo Sagara

Headquarters

Osaka, 541-8564, JP

OPHLY Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

16%

Net Income Margin

12%

Return on Equity

8%

Return on Capital

9%

Return on Assets

6%

Earnings Yield

6.11%

Dividend Yield

3.65%

Payout Ratio

59.97%

Stock Overview

Market Cap

$6.85B

Shares Outstanding

1.41B

Volume

33.04K

Avg. Volume

27.69K

Financials (TTM)

Gross Profit

$338.92B

Operating Income

$59.75B

EBITDA

$91.54B

Operating Cash Flow

$82.46B

Capital Expenditure

$7.99B

Free Cash Flow

$74.47B

Cash & ST Invst.

$210.38B

Total Debt

$146.68B

Ono Pharmaceutical Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2026YOY CHG

Revenue

$142.43B

+6.1%

Gross Profit

$105.08B

+18.9%

Gross Margin

73.78%

N/A

Market Cap

$6.85B

N/A

Market Cap/Employee

$1.78M

N/A

Employees

3,853

N/A

Net Income

$29.38B

+96.5%

EBITDA

$48.06B

+99.9%

Quarterly Fundamentals

Name
Q3 2026YOY CHG

Net Cash

$57.31B

+246.2%

Accounts Receivable

$149.59B

-1.7%

Inventory

$66.14B

-14.8%

Long Term Debt

$97.71B

-19.4%

Short Term Debt

$34.38B

+4.2%

Return on Assets

5.75%

N/A

Return on Invested Capital

8.85%

N/A

Free Cash Flow

$32.02B

+58459.9%

Operating Cash Flow

$33.04B

+52311.7%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
GZPHFGuangzhou Baiyunshan Pharmaceutical Holdings Company Limited
$2.34+0.00%
KYKOFKyowa Kirin Co., Ltd.
$15.05+0.00%
FLMNFFielmann AG
$50.75+0.00%
HKMPYHikma Pharmaceuticals PLC
$37.21+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$7.71+2.33%
GBTGGlobal Business Travel Group
$9.34+0.57%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.21+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.69-0.00%

Questions About OPHLY

What is the current price of Ono Pharmaceutical?

Ono Pharmaceutical is trading at $4.86 per share.

What is the 52-week range for Ono Pharmaceutical?

Over the past 52 weeks, Ono Pharmaceutical has traded between $3.28 and $5.75.

How much debt does Ono Pharmaceutical have?

As of the most recent reporting period, Ono Pharmaceutical reported total debt of $793.84M.

How much cash does Ono Pharmaceutical have on hand?

Ono Pharmaceutical reported $1.20B in cash and cash equivalents in its most recent financial results.

What is Ono Pharmaceutical’s dividend yield?

Ono Pharmaceutical currently has a dividend yield of 3.65%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.